Should HFrEF patients with NYHA class II expect benefit from CCM therapy?: Results from the MAINTAINED observational study - Fastner, Christian; Yücel, Gökhan; Hetjens, Svetlana; Rudic, Boris; Schmiel, Gereon; Toepel, Matthias; Liebe, Volker; Kruska, Mathieu; Borggrefe, Martin; Burkhoff, Daniel; Akın, Ibrahim; Dürschmied, Daniel; et al. (Clinical research in cardiology, 2022)
Gesehen am 10.07.2023